Overall, CYP19A1 levels were not significantly associated with rs10046 genotypes in breast tumors or breast cancer cell lines (P = 0.256 and P = 0.061, respectively; ANOVA; Fig. 1a, b). Here, CYP19A1 is linked to breast neoplasm.